MediPharm Labs Corp. (FRA:MLZ)

Market Cap	17.14M -12.6%
Revenue (ttm)	28.21M +18.1%
Net Income	-4.91M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	161
Open	0.0396
Previous Close	0.0398
Day's Range	0.0396 - 0.0396
52-Week Range	0.0318 - 0.0700
Beta	n/a
RSI	51.90
Earnings Date	Mar 27, 2026

About MediPharm Labs

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll canna...

• Industry: Pharmaceutical Preparations
• Founded: 2015
• Employees: 161
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MLZ

Financial Performance

In 2024, MediPharm Labs's revenue was 41.96 million, an increase of 26.92% compared to the previous year's 33.06 million. Losses were -10.69 million, -18.26% less than in 2023.

Financial numbers in CAD